CYFUSE BIOMEDICAL K K financial statements, including revenue, expenses, and profit

The total revenue of 4892 for the last quarter is 28.14 M JPY, and it's 240.35% higher compared to the previous quarter. The net income of Q4 24 is -208.06 M JPY.